CLINICAL_TRIALS
trial_result
· 2016-06-28
Clinical Trial Update: FGF-23 Suppressibility by Calcitonin [NA]
Summary
A completed clinical trial investigated whether calcitonin can suppress FGF-23 in patients with hypophosphatemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rijnstate Hospital | Conditions: Hypophosphatemia | NA | Status: COMPLETED